BALPHARMA — Bal Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.71bn
- IN₹2.99bn
- IN₹3.39bn
- 68
- 46
- 40
- 52
Annual cashflow statement for Bal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -135 | 41 | 91.8 | 47.5 | 90.5 |
| Depreciation | |||||
| Non-Cash Items | 113 | 116 | 81.1 | 123 | 123 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 178 | -34.6 | 4.59 | -280 | -85.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 232 | 218 | 268 | -18.4 | 228 |
| Capital Expenditures | -50.6 | -34.1 | -84.7 | -146 | -110 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.58 | -15.7 | -10.2 | -75.4 | -79.1 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -47.1 | -49.8 | -94.8 | -222 | -189 |
| Financing Cash Flow Items | -123 | -86.5 | -94.9 | -129 | -171 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -200 | -166 | -172 | 244 | -12.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.8 | 1.65 | 0.892 | 3.74 | 27.1 |